Dr. Mark Heise Inks Deal with Moderna Therapeutics to Develop Improved Models to Study Vaccine Safety and Immunogenicity
Mark Heise, PhD (Professor, Genetics and Microbiology & Immunology) was awarded a scientific research agreement from Moderna Therapeutics to utilize the Collaborative Cross (CC) to improve models to study the safety and immunogenicity of vaccines.